Comments

Elevation Oncology Stock Price, Quotes and Forecasts

Q: What sector and industry does Elevation Oncology (ELEV) operate in?

Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ELEVNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.5123

0.036.95%

Pre-Market: 6:00 AM EDT

Elevation Oncology (ELEV) Forecast

News Earnings Elevation Oncology (ELEV) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Elevation Oncology Stock Price, Quotes and Forecasts | NASDAQ:ELEV | Benzinga

Explore Elevation Oncology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ELEV.

Open	-
Close	-
Volume / Avg.	9.69K / 2.25M
Day Range	- - -
52 Wk Range	0.48 - 5.83
Market Cap	$30.29M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	15.7%
Days to Cover	7.03

Recent News

Elevation Oncology: Promising Cancer Therapies Earn Analyst Praise

Elevation Oncology's ADCs target CLDN18.2 and HER3, with EO-3021 showing promising Phase 1 results and a $6.6 billion TAM in gastric and pancreatic cancers.

Vandana Singh

This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday

Avi Kapoor

S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	9.69K / 2.25M
Day Range	- - -
52 Wk Range	0.48 - 5.83
Market Cap	$30.29M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	15.7%
Days to Cover	7.03

About Elevation Oncology Inc

Sector

Health Care

Industry

Biotechnology

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics fo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Elevation Oncology (ELEV) stock?

You can purchase shares of Elevation Oncology (NASDAQ:ELEV) through any online brokerage.

View our list of the best stock brokerages

Who are Elevation Oncology (ELEV) competitors?

Other companies in Elevation Oncology’s space includes: Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP), Palatin Techs (AMEX:PTN), OS Therapies (AMEX:OSTX) and Abpro Hldgs (NASDAQ:ABP).

What is the forecast, or price target, for Elevation Oncology (ELEV) stock?

Elevation Oncology has a consensus price target of $6.56.

What is the current price for Elevation Oncology (ELEV)?

The stock price for Elevation Oncology (NASDAQ: ELEV) is $0.5123 last updated March 4, 2025 at 6:00 AM EST.

Does Elevation Oncology (ELEV) pay a dividend?

There are no upcoming dividends for Elevation Oncology.

When is Elevation Oncology (NASDAQ:ELEV) reporting earnings?

Elevation Oncology’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is Elevation Oncology (ELEV) going to split?

There is no upcoming split for Elevation Oncology.

What sector and industry does Elevation Oncology (ELEV) operate in?

Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.